Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05290558 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 10, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 200 to confirmed 59
    • Site details revised
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Primary endpoints revised (4)
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 1, 2022 to Jan 7, 2022
    • Eligibility criteria shortened, about 43 words
    • Secondary endpoints revised (2)
    • Study description shortened, about 6 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the safety and efficacy of Bu Shen Yi Jing (BSYJ) Pill , a type of traditional Chinese medicine, in improving male subfertility and semen parameters.
Trial Details
NCT Number NCT05290558
Lead Sponsor KK Women's and Children's Hospital
Conditions
(from sponsor)		 Male Infertility, Infertility, Traditional Chinese Medication (TCM), Reproductive Issues
Related terms Infertility, Infertility, Male
Enrollment 59 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov